RFC
ATOS icon

Regions Financial Corp’s Atossa Therapeutics ATOS Stock Holding History

Regions Financial Corp’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,000
Closed -$17.7K – 862
2025
Q4 		$17.7K Hold
2,000
– – ﹤0.01% 831
2025
Q3 		$26K Hold
2,000
– – ﹤0.01% 830
2025
Q2 		$24.9K Hold
2,000
– – ﹤0.01% 843
2025
Q1 		$20.2K Hold
2,000
– – ﹤0.01% 809
2024
Q4 		$28.3K Hold
2,000
– – ﹤0.01% 811
2024
Q3 		$45.6K Hold
2,000
– – ﹤0.01% 824
2024
Q2 		$35.7K Hold
2,000
– – ﹤0.01% 816
2024
Q1 		$54K Hold
2,000
– – ﹤0.01% 825
2023
Q4 		$26.4K Buy
+2,000
New +$21.6K ﹤0.01% 813

Other funds holding ATOS

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Regions Financial Corp's ATOS Position: Q1 2026 in Review

Regions Financial Corp sold out of Atossa Therapeutics (ATOS) in Q1 2026, closing a stake of 2,000 shares — an estimated $17.7K sold.

Regions Financial Corp first reported a position in ATOS in Q4 2023 and held it in 9 quarters. The position peaked at $54K in Q1 2024. 33 funds tracked by Wall St. Rank hold ATOS as of Q1 2026.

  • Regions Financial Corp reported no remaining Atossa Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Regions Financial Corp sold 2,000 Atossa Therapeutics shares in Q1 2026, an estimated $17.7K.
  • Regions Financial Corp first reported a position in Atossa Therapeutics in Q4 2023 and held it in 9 quarters.
  • Regions Financial Corp's Atossa Therapeutics position peaked at $54K in Q1 2024.
  • 33 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q1 2026.

Based on Regions Financial Corp's 13F filing for Q1 2026, filed 5 May 2026.